LabCorp Venture Fund logo

LabCorp Venture Fund

North America, North Carolina, United States, Burlington

Description

LabCorp Venture Fund invests in early stage private companies operating in current or strategically adjacent spaces.

Investor Profile

LabCorp Venture Fund has backed more than 12 startups, with 2 new investments in the last 12 months alone. The firm has led 3 rounds, about 25% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Switzerland, Denmark.
  • Strong thematic focus on Health Care, Biotechnology, Health Diagnostics.
  • Led 2 rounds in the past year.

Stage Focus

  • Series Unknown (42%)
  • Series B (17%)
  • Series A (17%)
  • Convertible Note (8%)
  • Seed (8%)
  • Series E (8%)

Country Focus

  • United States (83%)
  • Switzerland (8%)
  • Denmark (8%)

Industry Focus

  • Health Care
  • Biotechnology
  • Health Diagnostics
  • Medical
  • Clinical Trials
  • Product Research
  • Medical Device
  • Wearables
  • Women's
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LabCorp Venture Fund frequently co-invest with?

Launch NY
North America, New York, United States, Buffalo
Co-Investments: 1
Breakout Ventures
North America, California, United States, San Francisco
Co-Investments: 2
LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 1
BA
North America, New York, United States, Buffalo
Co-Investments: 1
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
G9 Ventures
North America, New York, United States, New York
Co-Investments: 1
RH Capital
North America, California, United States, San Francisco
Co-Investments: 2
Rochester Angel Network
North America, New York, United States, West Henrietta
Co-Investments: 2
Amboy Street Ventures
North America, California, United States, Los Angeles
Co-Investments: 1
Western New York Impact Investment Fund
North America, New York, United States, Buffalo
Co-Investments: 2

What are some of recent deals done by LabCorp Venture Fund?

Prenosis

Chicago, Illinois, United States

Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.

Artificial Intelligence (AI)BiopharmaHealth CareHospitalMachine LearningMedicalPharmaceuticalPrecision Medicine
Series AJan 29, 2026
Amount Raised: $20,000,000
Precede Biosciences

Boston, Massachusetts, United States

Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.

BiopharmaBiotechnologyHealth CareLife Science
Series BJan 12, 2026
Amount Raised: $63,500,000
BIOMAKERS

Recoleta, Distrito Federal, Argentina

BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.

BioinformaticsBiopharmaBiotechnologyMedicalTherapeutics
Series AJan 12, 2026
Amount Raised: $8,000,000
IMVARIA

Berkeley, California, United States

IMVARIA brings artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious diseases.

Health CareHealth DiagnosticsMedical Device
Series UnknownJan 7, 2026
Cellens

Medford, Massachusetts, United States

Cellens is a medical device company that provides clarity and focus on cancer detection.

Health CareMedicalMedical Device
SeedDec 23, 2025
Amount Raised: $6,500,000
Emm

London, England, United Kingdom

Emm is developing the next generation of bio-wearables for better healthcare

Biotechnology
SeedNov 19, 2025
Amount Raised: $8,880,821
SiteLabs

Anderson, South Carolina, United States

SiteLabs engages in testing platform option that will streamline and automate your testing process workflow.

Health CareMedicalTest and Measurement
SeedNov 6, 2025
Amount Raised: $2,000,000
Praia Health

Chicago, Illinois, United States

Praia Health is a modern consumer platform for health systems that transforms the delivery of tailored health solutions on a large scale.

Health CareHospitalMedicalWellness
Series UnknownNov 4, 2024
GLX Analytix

Copenhagen, Hovedstaden, Denmark

At GLX Analytix, we combine a new, proprietary class of blood biomarker with AI to bring personalized medicine to your healthcare.

BiotechnologyHealth CareMedicalPrecision Medicine
Series UnknownOct 29, 2024
NOWDiagnostics

Springdale, Arkansas, United States

NOWDiagnostics develops and manufactures diagnostic tests that utilize a single drop of blood and deliver results within minutes.

Health DiagnosticsManufacturingMedical Device
Series BJul 9, 2024
Amount Raised: $22,500,000

Find More Investors Like LabCorp Venture Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides